In the paper, published in Nature, scientists from Philadelphia-based University of Pennsylvania and New York City-based Memorial Sloan Kettering Cancer Center detail a new method to predict whether skin cancer patients will respond to certain immunotherapy treatments.
Silicon Valley entrepreneur and philanthropist Sean Parker, who co-founded Napster and served as Facebook’s founding president, founded the Parker Institute. Today, Mr. Parker serves as the organization’s chairman of the board.
Click here to view the full paper.
More articles on health IT:
5 things data scientists want hospital leaders to know
Metro Community Provider Network agrees to $400k HIPAA settlement
10 guidelines for ethical data research
